drugset / Trial / NCT06815653

Digital Intervention for Psychedelic Preparation (DIPP): Comparing Meditation and Music-Based Programs

NCT06815653

Phase 1 Recruiting 40 enrolled University College, London
RandomizedParallel-groupSingle-blindOther

Summary

This randomised controlled feasibility trial evaluates the Digital Intervention for Psychedelic Preparation (DIPP), a novel 21-day self-guided program designed to prepare individuals for psychedelic experiences. Forty healthy volunteers will be randomly assigned to either a meditation-based intervention or a music-based control condition. Both groups will follow identical program structures, with the key distinction being their daily practice focus: meditation or music listening. Following the 21-day preparation period, participants will undergo a supervised 25 mg psilocybin session at University College London. Assessment visits include an in-person follow-up at 2 weeks post-session, followed by online assessments at 3, 6, and 9 months. The primary outcomes include operational feasibility (recruitment rates and participant retention) and intervention adherence (completion rates of DIPP program activities). Secondary outcomes include participant ratings of the platform's feasibility, acceptability, and usability, as well as changes in psychedelic preparedness, the quality of the psychedelic experience, and mental wellbeing over time.

Timeline

Start
2025-03-01
Primary completion
2026-03
Completion
2026-12

Drugs

EvaluationDrugModalityDoseRoute
Background Psilocybin Other / unclassified 25 mg Oral

Indications

No indication recorded.